Creating the Foundation for Real-Time Healthcare

Bernoulli Health Publishes New eBook on How Clinical Surveillance Impacts Patient Safety and Operational Efficiencies

New market education resource helps hospital leaders understand the patient safety aspects, integration, and cost benefits of clinical surveillance technologies

Milford, CT – March 20, 2018 – Bernoulli Health, the developer of the advanced Bernoulli One™ clinical surveillance, medical device integration (MDI), and real-time data analytics platform has released a new eBook entitled, Continuous Clinical Surveillance: A Business and Clinical Case for Creating the Foundation for Real-Time Healthcare. The eBook provides a framework for understanding the value and purpose of clinical surveillance technologies in hospitals and across enterprise health systems.

According to a new healthcare report published by Spyglass Consulting Group, Trends in Clinical Surveillance and Analytics 2018, the market requires further resources to help hospital leaders understand the role of clinical surveillance as it relates to patient and alarm safety, improving operational efficiencies, integration with other clinical systems, regulatory compliance, and the return on investments. Taking this into account, the new Bernoulli Health eBook covers key topics including:

  • Policies and recommendations for clinical surveillance set forth by organizations including Centers for Medicaid Services (CMS), The Joint Commission (TJC), and Anesthesia Patient Safety Foundation (APSF)
  • Risk management and patient safety aspects of clinical surveillance such as Hospital-Acquired Conditions (HAC), escalations in care, and early warning notifications
  • The impact of clinical surveillance to hospitals as it relates to resource utilization, workflow efficiencies, length of stay, and readmissions
  • Leveraging the hospital’s existing infrastructure including the EHR, ventilators, and medical devices as a starting point for integrating clinical surveillance technologies
  • And more

Bernoulli Health Chief Executive Officer, Janet Dillione, said, “There is still much confusion about clinical surveillance applications in hospitals. In our new eBook we share what we have learned about the clinical and cost benefits of clinical surveillance through experience working with our customers and from our systematic review of the literature.” Dillione added, “We’re pleased to see that others like Spyglass Consulting Group are publishing new content to help educate the market on clinical surveillance technologies which are often confused with patient monitoring, clinical decision support (CDS), and even Artificial Intelligence (AI) technologies. Once healthcare leaders have a better understanding of these technologies, they can make more informed decisions about which will work best in their clinical environments.”

About Bernoulli Health

The mission of Bernoulli® Health is to improve patient safety in real time. Since 1989, Bernoulli has developed solutions including the all-inclusive Bernoulli One platform. A single solution for continuous patient health monitoring and clinical surveillance, medical device integration, and real-time data analytics, there are no other solutions as advanced as Bernoulli One. The Bernoulli software helps save patient lives as it continuously detects deteriorating patient conditions and notifies clinicians of potential events. This results in improved patient observation and provider workflows. Bernoulli has achieved FDA Class II clearance for use in both patient monitoring and secondary alarm management. Bernoulli headquarters are in Milford, CT. For more information visit, email, or call 800-337-9936.